🇺🇸 FDA
Company

PRECISION

PRECISION BIOSCIENCES INC

DTIL biotech USA

Quick answer

PRECISION is a biotech company (DTIL) headquartered in DURHAM, NC, USA with 24 tracked pipeline programs.

Pipeline (24)

project

1.0mg/kg/day PRAX-562

Developmental and Epileptic Encephalopathy 1

Phase 3 · small_molecule · active

1 trials project

18F fluciclovine

Brain Metastases

Phase 3 · small_molecule · completed

2 trials project

1mg elsunersen

Epileptic Encephalopathy

Phase 3 · small_molecule · active

1 trials project

20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks

Focal Seizure

Phase 3 · small_molecule · active

1 trials project

40 mg/day vormatrogine for 12 weeks

Focal Epilepsy

Phase 3 · small_molecule · active

1 trials project

60 mg ulixacaltamide

Essential Tremor

Phase 3 · small_molecule · active

1 trials project

Early Vasopressin

Septic Shock

Phase 3 · small_molecule · active

1 trials project

ICT-107

Glioblastoma Multiforme

Phase 3 · mab · completed

2 trials project

PRAX-114

Major Depressive Disorder

Phase 3 · small_molecule · completed

1 trials project

PRAX-562

SCN2A Encephalopathy

Phase 3 · small_molecule · active

1 trials project

vormatrogine

Epilepsy, Tonic-Clonic

Phase 3 · small_molecule · active

1 trials project

10 mg PRAX-114

Major Depressive Disorder

Phase 2 · small_molecule · completed

1 trials project

10 mg PRAX-114, 20 mg PRAX-114, and Placebo

Essential Tremor

Phase 2 · small_molecule · terminated

1 trials project

100 mg PRAX-944

Essential Tremor

Phase 2 · small_molecule · completed

1 trials project

30mg PRAX-628

Focal Onset Seizure

Phase 2 · small_molecule · active

1 trials project

60 mg PRAX-114 or 40 mg PRAX-114

Post-traumatic Stress Disorder

Phase 2 · small_molecule · terminated

1 trials project

Atorvastatin Oral Tablet

Mild Cognitive Impairment

Phase 2 · small_molecule · active

1 trials project

BCMA CAR-T cells

Multiple Myeloma

Phase 2 · mab · active

2 trials project

BCMA targeted prime CAR-T cells

Multiple Myeloma

Phase 2 · mab · active

1 trials project

CD123 CAR-T cells

Leukemia

Phase 2 · mab · active

2 trials project

CD123 targeted CAR-NK cells

Acute Myeloid Leukemia

Phase 2 · mab · active

1 trials project

CD19 CAR-T cells

Autoimmune Diseases

Phase 2 · mab · active

1 trials project

CD19 CAR-T cells

Leukemia

Phase 2 · mab · active

2 trials project

CD19 and CD22 targeted CAR-T cells

Leukemia, B-cell

Phase 2 · mab · active

2 trials

Drugs (5)

drug

ammonia n-13

AMMONIA N 13

 drug

fludeoxyglucose f-18

FLUDEOXYGLUCOSE F18

 drug

hydrocortisone butyrate

HYDROCORTISONE BUTYRATE

 drug

phentolamine mesylate

PHENTOLAMINE MESYLATE

 drug

sodium fluoride f-18

SODIUM FLUORIDE F-18

Patents (8)

patent

US 12419920

Bifidobacterium longum NCIMB 41676

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12410418

Optimized engineered meganucleases having specificity for a recognition sequence

Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351839

Rationally-designed single-chain meganucleases with non-palindromic recognition

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12344676

Recombinant monoclonal antibodies and corresponding antigens for colon and pancr

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12336835

Neuromodulation to target glucose transporter and/or incretin pathways

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12232492

Disinfection of bacteriophages products using supercritical carbon dioxide

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12233135

Therapeutic constructs for treating cancer

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12180463

Lactobacillus reuteri

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)